Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche’s pursuit of Ventana continues

This article was originally published in The Gray Sheet

Executive Summary

Roche will seek election of alternative Ventana board members at the latter firm's next annual shareholder meeting, slated for June 2008, as part of an ongoing effort to acquire the cancer test maker, Roche says Dec. 5. The firms entered into a confidentiality agreement Nov. 13 so that Roche could commence a due diligence review of Ventana's business after Roche initiated a hostile $3 billion takeover offer last June (valued at $75 per share). Ventana rejects the offer as inadequate (1"The Gray Sheet" Nov. 19, 2007, In Brief)

You may also be interested in...

Ventana warming to Roche deal?

Tissue-based cancer test firm Ventana Medical Systems enters into a confidentiality agreement with Roche, allowing the latter firm to begin a due diligence review with an eye toward potentially acquiring Ventana, the firms announce Nov. 13. However, Ventana still believes Roche's current hostile offer of $3 billion ($75 per share) is "grossly inadequate." Roche initiated the offer in June and renewed it for the fourth time last month (1"The Gray Sheet" Nov. 5, 2007, p. 18). Ventana believes that the due diligence and "related discussions" will allow Roche to recognize the "significant additional value inherent in Ventana's business," potentially resulting in a richer offer. However, the likelihood of a deal remains uncertain, both firms say. Ventana stock closed at $90.08 on Nov. 16

Becton Dickinson, BioMedomics Collaborate On Rapid Serology COVID-19 Test

BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.

Industry Asks If Small Business Loan Relief Applies To Companies With Equity Investors

A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts